2m 2m 2m 2m 2m 2m 2m
CERVOMED (CRVO)
NASDAQ
$3.08+$0.15 (+5.12%)
Price as of Oct 02, 2026 7:09 PM EDT- $44.3MMarket Cap
- -64.14%1-Year Change
- BiotechnologyIndustry
CERVOMED (CRVO)
$3.08+$0.15 (+5.12%)
CRVO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.93 | ||
Change | -$0.04 (-1.35%) | ||
Open | $2.98 | ||
High | $2.98 | ||
Low | $2.86 | ||
Previous Close | $2.97 | ||
Volume | 175,071 | ||
30-Day Average Volume | 183,057 | ||
1-Week Change | 16.27% | ||
1-Month Change | 14.01% | ||
1-Year Change | -64.14% | ||
3-Year Change | -36.58% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.1M | ||
Total Assets | $26.0M | ||
Market Cap | $44.3M | ||
Enterprise Value | $21.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.6M | ||
Free Cash Flow | -$6.9M | ||
EBIT | -$6.6M | ||
EBITDA | -$6.6M | ||
Net Working Capital | $25.3M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 04/19/2022 | ||
Earnings & Revenue